In Vitro Diagnostics: World Market Outlook 2013-2023

  • August 2013
  • -
  • Visiongain
  • -
  • 137 pages

Report Details

In vitro diagnostic tests - your guide to trends and revenue prospects

What's the future of in vitro diagnostic (IVD) testing? Visiongain's updated report predicts those revenues to 2023. There you find the best places for sales growth, also understanding trends, technologies, and opportunities.

That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what's happening for those technologies, finding how you can gain.

Read on to explore that industry and see what its future market could be worth.

Forecasts 2013-2023 and other analyses to help you understand IVD potential

Besides revenue forecasting to 2023, our new work shows recent results, growth rates, and market shares. There you find original analysis. See technological developments too. You also get 52 tables, 40 charts, and two interviews.
Many opportunities remain for those technologies and products. Now see how you can benefit your research, analyses, and decisions for IVD, also saving time.
You hear what's happening there and see where the money lies. That way you reduce your risk of missing out. Finding data you need there just got easier. Try our new report.

The following sections show, then, how you benefit from our new investigation and analysis.

Prospects from 2013 for the world market and submarkets

What are the secrets of that industry's progress? Along with prediction of the overall world market for IVD, our work shows you individual revenue forecasting of seven submarkets to 2023 at world level:
• Point-of-care testing
• Clinical chemistry
• Immunochemistry
• Haematology-based applications (hematology)
• Microbiology-based tests
• Genetic-based testing
• Other systems (grouped forecast).

See how and why those segments can prosper. That analysis helps you identify potential for in vitro diagnostic testing products. Assess how those tools, agents, and systems can make money.

Our study gives you feel for what stimulates and restrains that industry and market. You see prospects for established and emerging technology and competition. That market will grow through the R&D, approval and launch of many products. See how you can benefit.

You also find that healthcare industry's geographical revenue prospects.

National markets - where will highest revenues and growth occur?

Our analyses show you individual revenue forecasts to 2023 for 11 national markets:
• United States (US)
• Japan
• EU leaders - Germany, France, the UK, Italy, and Spain (EU5)
• BRIC countries - Brazil, Russia, India, and China.

Many commercial opportunities exist in developed and developing countries. Our study explains, assessing progress and prospects.
There you assess the IVD industry's future - hear about developments and find their significance. Our work explains, exploring crucial issues.

Issues and events - what affects developers, producers and sellers?

The report lets you assess trends and outlooks for IVD companies. There, looking ahead, you find discussions of issues and developments:
• Regulations for approval and reimbursement
• Advances in technology benefiting IVD methods
• Competition driving consolidation and innovation
• Tests applying biomarkers.

That investigation discusses other aspects of the technology too, including these:
• Immunoassays and automated systems
• Genetic testing, including direct-to-consumer (DTC) screening
• Cytogenetic tools
• Theranostics - targeting patients' needs through DNA testing.

There you explore political, economic, social, and technological questions, assessing advances and outlooks for business. See, then, what stimulates and restrains that industry. Discover what its present and future hold.

Companies and 2017 market value - what happens nex

Table Of Contents

In Vitro Diagnostics: World Market Outlook 2013-2023
1. Executive Summary

1.1 Highlights from the Study
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outlines
1.4 Research and Analysis Methods
1.5 Glossary

2. Introduction to In Vitro Diagnostics

2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 The US Classification
2.2.2 The EC (European Commission) Classification
2.2.3 Regulatory Issues in the IVD Market
2.2.3.1 Regulation of IVD Tests
2.2.3.2 Lack of Clarity Can Be Costly
2.3 What are the Different Types of IVD Tests?
2.3.1 Point Of Care Diagnostics- The Most Prominent Type
2.3.2 Clinical Chemistry Is Not to Be Discounted
2.3.3 Microbiology
2.3.3.1 Regulatory Differences With IVD Microbiology Tests
2.3.4 Haematology
2.3.5 Immunochemistry
2.3.6 Genetic Testing

3. The Global In Vitro Diagnostics Market, 2013-2023

3.1 In Vitro Diagnostics Market, 2012 - Nothing Radically Different
3.2 Global IVD Market Forecast, 2013-2023 - Three Sectors Dominate
3.2.1 Expected IVD Industry Trends Over 2013-2023
3.2.1.1 Advances in Technology Driving the IVD Market
3.2.1.2 Decentralisation Will Play its Part Too
3.2.1.3 Increased Awareness of Need for IVD Tests

4. Leading National IVD Markets, 2013-2023

4.1 Regional Breakdown of the Global IVD Market, 2012
4.2 The Global IVD Market: Regional Forecast, 2013-2023
4.3 The US Market - Still the Global Leader
4.3.1 Increased Levels of Molecular Testing in the US
4.3.2 Increased Use of Mobile Applications
4.3.3 Centralisation of Testing Facilities and the Impact of the Patient Protection and Affordable Care Act (PPACA)
4.4 The EU5 - Europe's Engine
4.4.1 Germany and France - In the Centre of Europe
4.4.2 United Kingdom - Still a Major Player
4.4.3 Spain
4.4.4 Italy - Still Reeling
4.5 The Japanese Market - The Sun Keeps on Rising
4.6 The BRIC Nations - Today's Growth Engines, Tomorrow's Leaders?
4.6.1 The Brazilian Market
4.6.2 The Russian Market - Many Growth Opportunities Exist for Sales
4.6.3 The Indian Market - A Massive Expansion is Expected
4.6.4 The Chinese Market - A Cut Above the Rest

5. In Vitro Diagnostics Market Sectors, 2013-2023

5.1 Point-of-Care Diagnostics - A Revolution in the Making?
5.1.1 POC Diagnostics Market, 2012
5.1.2 POC Diagnostics: Market Forecast, 2013-2023
5.1.3 POC Diagnostics: Market Trends, 2013-2023
5.1.3.1 New Tests Targeting Biomarkers Will Be Crucial
5.1.3.2 Competition Driving Consolidation and Product Innovation
5.1.3.3 Infectious Diseases Prompting Growth of POC
5.1.3.4 Other Factors Influencing the Influencing the POC Segment
5.1.4 Profile: Roche's Accutrend Plus System
5.2 Clinical Chemistry Still Going Strong
5.2.1 Clinical Chemistry: Market Forecast, 2013-2023
5.2.2 Clinical Chemistry: Market Trends, 2013-2023
5.2.3 Profile: Siemens' ADVIA 2400 Chemistry System
5.3 Immunochemistry - Attack of the Antibodies
5.3.1 Immunochemistry: Market Forecast, 2013-2023
5.3.2 Immunochemistry: Market Trends, 2013-2023
5.3.2.1 Immunoassays and Automated Systems Prompting Market Growth
5.3.2.2 Strong Growth in China and India
5.3.3 Profile: Roche's Elecsys Anti-HBc IgM Immunoassay
5.4 Haematology - An Ever Present Medical Need
5.4.1 Haematology: Market Forecast, 2013-2023
5.4.2 Haematology: Market Trends, 2013-2023
5.4.3 Profile: Sysmex's XN Series
5.5 Microbiology - A Declining Segment?
5.5.1 Microbiology: Market Forecast, 2013-2023
5.5.2 Microbiology: Market Trends, 2013-2023
5.5.3 Profile: bioMerieux's Vitek 2 System
5.6 Genetic Testing - The Future of the Industry?
5.6.1 Genetic Testing: Market Forecast, 2013-2023
5.6.2 Genetic Testing: Market Trends, 2013-2023
5.6.2.1 Cytogenetic Tests to Drive Market Growth
5.6.2.2 Direct-To-Consumer (DTC) Genetic Screening
5.6.2.3 Ther

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market

2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market

  • $ 23 500
  • Industry report
  • May 2015
  • by Venture Planning Group

"2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market" is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

2015 Automated Microbiology Market-- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

2015 Automated Microbiology Market-- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

  • $ 22 400
  • Industry report
  • May 2015
  • by Venture Planning Group

Complete report $35,500.  DataPack (test volumes, sales forecasts, supplier shares) $22,400. “2015 Global Automated Microbiology Market” is a new seven-country strategic analysis of the major business ...

2015 Strategies in the Global Microbiology Market

2015 Strategies in the Global Microbiology Market

  • $ 21 100
  • Industry report
  • May 2015
  • by Venture Planning Group

2015 Strategies in the Global Microbiology Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.